153 related articles for article (PubMed ID: 29135311)
21. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
22. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
Zhang Y; Sturgis EM; Li Y; Wei Q; Huang Z; Li G
Sci Rep; 2017 Jan; 7():39765. PubMed ID: 28045062
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
Zhang C; Sturgis EM; Zheng H; Song X; Wei P; Jin L; Chao L; Wei Q; Li G
Int J Cancer; 2014 Apr; 134(8):1907-15. PubMed ID: 24122460
[TBL] [Abstract][Full Text] [Related]
24. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
[TBL] [Abstract][Full Text] [Related]
25. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
26. Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma.
Corrêa GT; Bandeira GA; Cavalcanti BG; de Carvalho Fraga CA; dos Santos EP; Silva TF; Gomez RS; Guimarães AL; De Paula AM
Oral Oncol; 2011 Sep; 47(9):888-94. PubMed ID: 21788151
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
30. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.
Jain M; Kumar S; Upadhyay R; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Biol Ther; 2007 Oct; 6(10):1553-8. PubMed ID: 17912028
[TBL] [Abstract][Full Text] [Related]
31. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.
Knopf A; Lempart J; Bas M; Slotta-Huspenina J; Mansour N; Fritsche MK
Oncotarget; 2015 Feb; 6(5):3443-51. PubMed ID: 25633809
[TBL] [Abstract][Full Text] [Related]
32. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
33. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
[TBL] [Abstract][Full Text] [Related]
34. Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India.
Gorre M; Mohandas PE; Kagita S; Cingeetham A; Vuree S; Jarjapu S; Nanchari S; Meka PB; Annamaneni S; Dunna NR; Digumarti R; Satti V
Asian Pac J Cancer Prev; 2016; 17(2):815-21. PubMed ID: 26925685
[TBL] [Abstract][Full Text] [Related]
35. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
[TBL] [Abstract][Full Text] [Related]
37. Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer.
López RV; Zago MA; Eluf-Neto J; Curado MP; Daudt AW; da Silva-Junior WA; Zanette DL; Levi JE; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho JF; Boffetta P; Wünsch-Filho V
Braz J Med Biol Res; 2011 Oct; 44(10):1006-12. PubMed ID: 21845339
[TBL] [Abstract][Full Text] [Related]
38. BCL2 genotypes and prostate cancer survival.
Renner W; Langsenlehner U; Krenn-Pilko S; Eder P; Langsenlehner T
Strahlenther Onkol; 2017 Jun; 193(6):466-471. PubMed ID: 28396899
[TBL] [Abstract][Full Text] [Related]
39.
Costa EFD; Lima TRP; Lopes-Aguiar L; Nogueira GAS; Visacri MB; Quintanilha JCF; Pincinato EC; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
Tumour Biol; 2020 Jul; 42(7):1010428320938494. PubMed ID: 32628088
[TBL] [Abstract][Full Text] [Related]
40. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases.
Ai L; Vo QN; Zuo C; Li L; Ling W; Suen JY; Hanna E; Brown KD; Fan CY
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):150-6. PubMed ID: 14744748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]